EPIDERMOLYSIS BULLOSA
Clinical trials for EPIDERMOLYSIS BULLOSA explained in plain language.
Never miss a new study
Get alerted when new EPIDERMOLYSIS BULLOSA trials appear
Sign up with your email to follow new studies for EPIDERMOLYSIS BULLOSA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New gel could help heal painful skin wounds in rare disease
Disease control Recruiting nowThis study tests a gel called Oleogel-S10 on skin wounds from two types of epidermolysis bullosa (EB), a rare genetic condition that makes skin very fragile. About 6 Japanese children and adults will apply the gel to their wounds at dressing changes for 45 days, with the option t…
Matched conditions: EPIDERMOLYSIS BULLOSA
Phase: PHASE3 • Sponsor: Chiesi Farmaceutici S.p.A. • Aim: Disease control
Last updated May 17, 2026 04:32 UTC
-
New combo therapy aims to heal wounds in rare skin disease
Disease control Recruiting nowThis study tests whether adding IV IgG treatment to standard VYJUVEK therapy can help wounds heal faster and reduce blistering in people with recessive dystrophic epidermolysis bullosa (RDEB), a rare genetic skin condition. Eight participants will receive IV IgG and be monitored …
Matched conditions: EPIDERMOLYSIS BULLOSA
Phase: PHASE1, PHASE2 • Sponsor: M. Peter Marinkovich • Aim: Disease control
Last updated May 13, 2026 15:59 UTC